ClinicalTrials.Veeva

Menu

Observational Study to Evaluate the Quality of Life of Healthy Postmenopausal Women Who Take Coenzyme Q-Ubiquinol

D

Dr. Santiago Palacios

Status

Completed

Conditions

Health Status

Treatments

Dietary Supplement: Coenzima Q - QubiquinolCoenzyme Q - Qubiquinol

Study type

Observational

Funder types

Other

Identifiers

NCT03429231
QUbiquinol17

Details and patient eligibility

About

Observational study about quality of life in postmenopausal women taking coenzyme Q compared to another group of women of the same age who do not take it

Full description

Observational study to evaluate the subjective assessment performed by healthy postmenopausal women who are taking coenzyme Q for 3 months, compared with other groups of the same characteristics that do not take it

Enrollment

40 patients

Sex

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Postmenopausal woman between 45 and 65 years old
  • Woman who is taking coenzyme Q-Ubiquinol and who will continue taking at least the next 3 months
  • Woman not taking Coenzyme Q-Ubiquinol and not going to take it in the next 3 months

Exclusión Criteria:

  • Patients with severe mental illness.
  • Suspicion or abuse of alcohol or other drugs during the 12 months prior to the selection
  • Any other consideration or finding that, in the opinion of the investigator, considers the non-participation of the subject in the study.

Trial design

40 participants in 2 patient groups

Active Group
Description:
Women who are taking coenzyme Q and who will continue taking it for 3 months
Treatment:
Dietary Supplement: Coenzima Q - QubiquinolCoenzyme Q - Qubiquinol
Control Group
Description:
Women who are not taking coenzyme Q and who will not take it in the next 3 months

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems